The anti-inflammatory and immuno-suppressive effects of glucocorticoids: recent developments and mechanistic insights

Research output: Contribution to journalReview articlepeer-review

Abstract / Description of output

Since the discovery of glucocorticoids in the 1940s and the recognition of their anti-inflammatory effects, they have been amongst the most widely used and effective treatments to control inflammatory and autoimmune diseases. However, their clinical efficacy is compromised by the metabolic effects of long term treatment, which include osteoporosis, hypertension, dyslipidaemia and insulin resistance/type 2 diabetes mellitus. In recent years, a great deal of effort has been invested in identifying compounds that separate the beneficial anti-inflammatory effects from the adverse metabolic effects of glucocorticoids, with limited effect. It is clear that for these efforts to be effective, a greater understanding is required of the mechanisms by which glucocorticoids exert their anti-inflammatory and immunosuppressive actions. Recent research is shedding new light on some of these mechanisms and has produced some surprising new findings. Some of these recent developments are reviewed here.
Original languageEnglish
Pages (from-to)2-13
JournalMolecular and Cellular Endocrinology
Volume335
Publication statusPublished - 2011

Fingerprint

Dive into the research topics of 'The anti-inflammatory and immuno-suppressive effects of glucocorticoids: recent developments and mechanistic insights'. Together they form a unique fingerprint.

Cite this